Investigation for optimal protocol using diluted ionic contrast medium during angiography

Investigation for optimal protocol using diluted ionic contrast medium during angiography - Diluted ionic contrast medium during angiography

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034174

Enrollment

200

Registered

2018-09-26

Start date

2018-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arterial diseases

Interventions

During the endovascular treatment for arterial diseases, angiogram using diluted ionic contrast medium will be performed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Any patient over 20 years old, who will be receiving endovascular treatment using ionic contrast medium, and has given written consent to participate to the study

Exclusion criteria

Exclusion criteria: 1) Patients allergic to ionic contrast medium 2) End stage renal insufficiency (eGFR < 15 ml/min) contraindicated to any ionic contrast medium 3) Patients determined to be unfit to participate the study by the attending physician. (for example, dementia)

Design outcomes

Primary

Measure	Time frame
Efficacy of diluted ionic contrast medium during endovascular treatment for arterial diseases	—

Secondary

Measure	Time frame
Effect of diluted contrast medium on kidney function	—

Countries

Japan

Contacts

Public ContactNaoki Fujimura

Saiseikai Central Hospital Cardiovascular Surgery

naokif0212@gmail.com03-3451-8211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026